Perry Jennifer Scott 4
4 · BICYCLE THERAPEUTICS PLC · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
Bicycle Therapeutics (BCYC) COO Jennifer Perry Sells Shares
What Happened
Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics plc (BCYC), sold a total of 1,412 shares in open-market transactions on July 2 and July 6, 2026, generating roughly $6,054 in proceeds. Transactions reported:
- July 2, 2026: 1,036 shares sold at a weighted avg price of $4.27, proceeds ~$4,424.
- July 6, 2026: 43 shares sold at a weighted avg price of $4.31, proceeds ~$185.
- July 6, 2026: 333 shares sold at $4.34, proceeds ~$1,445.
These were sales (not purchases); part of the activity includes a mandated sell-to-cover for tax withholding and a preplanned sale under a Rule 10b5-1 plan.
Key Details
- Transaction dates and prices:
- 2026-07-02: 1,036 shares @ $4.27 (weighted avg; range $4.26–$4.29 per footnote).
- 2026-07-06: 43 shares @ $4.31 (weighted avg; range $4.30–$4.31 per footnote).
- 2026-07-06: 333 shares @ $4.34 (reported as executed under a Rule 10b5-1 plan).
- Total proceeds: ≈ $6,054.
- Footnotes of note:
- F1: The July 2 sale represents a required "sell-to-cover" to satisfy statutory tax withholding related to RSU vesting (not a discretionary sale).
- F2/F3: Prices for the 1,036- and 43-share lots are weighted averages across multiple executions; the filer can provide detailed breakouts on request.
- F4: One July 6 sale was made pursuant to a Rule 10b5-1 trading plan adopted March 27, 2025 (preplanned).
- Shares owned after the transactions: not disclosed in the provided excerpt of the filing.
- Filing date: Form filed July 7, 2026. Form 4s are generally required within two business days of a transaction; the filing includes trades on July 2 and July 6 (check the full EDGAR filing for any timeliness notes).
Context
- Sell-to-cover transactions (F1) are routine to satisfy tax withholding when RSUs vest and are generally not considered discretionary insider selling.
- Sales executed under a 10b5-1 plan (F4) are preplanned and do not necessarily reflect current views by the insider.
- For a full view (ownership after the trades, exact per-trade price breakdowns, and any timeliness annotations), consult the complete Form 4 on SEC EDGAR.
Insider Transaction Report
Form 4
Perry Jennifer Scott
Chief Operating Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-07-02$4.27/sh−1,036$4,424→ 91,428 total - Sale
Ordinary Shares
[F1][F3]2026-07-06$4.31/sh−43$185→ 91,385 total - Sale
Ordinary Shares
[F4]2026-07-06$4.34/sh−333$1,445→ 91,052 total
Footnotes (4)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.31 inclusive.
- [F4]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2025.
Signature
/s/ Travis Thompson, Attorney-in-Fact|2026-07-07